The Avoca Group Selects Strategic Partner, Sitrof Technologies - Applied Clinical Trials

ADVERTISEMENT

See our 2012 Buyers Guide Digital Edition.
Find Pharma Search Engine
The Avoca Group Selects Strategic Partner, Sitrof Technologies

Source: Company News Release
Sitrof Technologies, a provider of IT and document management solutions for the life sciences industry, and The Avoca Group, a consulting and research organization specializing in clinical outsourcing and alliance management, today announced a strategic partnership specifically tailored for the life sciences industry.

“The Avoca Group provides comprehensive alliance and relationship management consulting services to the life sciences industry and we are always in search of best-of-breed solutions,” said Avoca President Patricia Leuchten. “By partnering with Sitrof Technologies our clients and Avoca Quality Consortium member companies will benefit as we streamline our processes through the application of the latest technologies available. In addition, as part of the partnership, Avoca and Sitrof will proactively identify ways that technology enablers can support Avoca's mission to help their clients build, measure and manage business relationships in the life sciences area."

Sitrof Technologies’ award-winning solutions have been deployed in dozens of life sciences companies including CROs, IRBs and other life sciences service partners in clinical trials, quality management and regulatory affairs. Founding partners Dan Wheeler and Bryan Reynolds have built a highly successful IT services business helping life sciences companies streamline and automate their processes.

“Unstructured content generation and the need for outsourcing are both growing at tremendous rates within life sciences companies, with no slow down in sight,” said Reynolds. “By working with The Avoca Group and Sitrof Technologies, life sciences companies can be assuredthey are implementing best practices in relationship management and qualitymanagement based on the most up-to-date, validated technologies and Business Process Management (BPM) platforms.”

Related Links:

The Avoca Group Announces Consortium on Quality Management and Oversight

The State of Clinical Outsourcing

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma
Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
90%
Borrow lightly from EMA's pathway program?
3%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Company News Release,
Click here